Table 3.
Unadjusted and adjusted Odds Ratios of poor outcomes in ischemic stroke patients with or without stroke history.
| - | Unadjusted OR (95% CI) | Adjusted OR (95% CI)* |
|---|---|---|
| 3-month | - | - |
| Death | 1.51 (1.33-1.72) | 1.18 (0.99-1.39) |
| MRS 3-6 | 1.66 (1.54-1.80) | 1.34 (1.20-1.49) |
| Recurrence | 1.68 (1.50-1.87) | 1.38 (1.21-1.57) |
| 6-month | - | - |
| Death | 1.63 (1.45-1.83) | 1.29 (1.11-1.51) |
| MRS 3-6 | 1.75 (1.62-1.89) | 1.41 (1.27-1.57) |
| Recurrence | 1.71 (1.54-1.89) | 1.40 (1.24-1.57) |
| 12-month | - | - |
| Death | 1.63 (1.47-1.81) | 1.34 (1.16-1.54) |
| MRS 3-6 | 1.82 (1.69-1.97) | 1.49 (1.34-1.66) |
| Recurrence | 1.79 (1.63-1.97) | 1.47 (1.31-1.65) |
*: Adjusting for potential confounders including age, gender, history of hypertension, dyslipidemia, diabetes mellitus, coronary heart disease and atrial fibrillation, family history of stroke, smoking, drinking, modified Rankin scale before stroke onset, NIHSS, medicine use before admission (anticoagulant, antiplatelet, antihypertensive, dyslipidemia, management of diabetes mellitus) and during hospitalization (tissue-type plasminogen activator, anticoagulant, antiplatelet, dyslipidemia, management of diabetes mellitus), and complications during hospitalization (urinary tract infection, pneumonia, gastrointestinal bleeding).